269 related articles for article (PubMed ID: 17575139)
1. CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells.
Pfenninger CV; Roschupkina T; Hertwig F; Kottwitz D; Englund E; Bengzon J; Jacobsen SE; Nuber UA
Cancer Res; 2007 Jun; 67(12):5727-36. PubMed ID: 17575139
[TBL] [Abstract][Full Text] [Related]
2. CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain.
Coskun V; Wu H; Blanchi B; Tsao S; Kim K; Zhao J; Biancotti JC; Hutnick L; Krueger RC; Fan G; de Vellis J; Sun YE
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1026-31. PubMed ID: 18195354
[TBL] [Abstract][Full Text] [Related]
3. In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133.
Barraud P; Stott S; Møllgård K; Parmar M; Björklund A
J Neurosci Res; 2007 Feb; 85(2):250-9. PubMed ID: 17131412
[TBL] [Abstract][Full Text] [Related]
4. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
[TBL] [Abstract][Full Text] [Related]
5. Prospectively isolated CD133/CD24-positive ependymal cells from the adult spinal cord and lateral ventricle wall differ in their long-term in vitro self-renewal and in vivo gene expression.
Pfenninger CV; Steinhoff C; Hertwig F; Nuber UA
Glia; 2011 Jan; 59(1):68-81. PubMed ID: 21046556
[TBL] [Abstract][Full Text] [Related]
6. CD133 expression by neural progenitors derived from human embryonic stem cells and its use for their prospective isolation.
Peh GS; Lang RJ; Pera MF; Hawes SM
Stem Cells Dev; 2009 Mar; 18(2):269-82. PubMed ID: 18651819
[TBL] [Abstract][Full Text] [Related]
7. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
[TBL] [Abstract][Full Text] [Related]
8. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
[TBL] [Abstract][Full Text] [Related]
9. Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme.
Schrot RJ; Ma JH; Greco CM; Arias AD; Angelastro JM
J Neurooncol; 2007 Nov; 85(2):149-57. PubMed ID: 17516028
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
[TBL] [Abstract][Full Text] [Related]
11. Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.
Tchoghandjian A; Baeza-Kallee N; Beclin C; Metellus P; Colin C; Ducray F; Adélaïde J; Rougon G; Figarella-Branger D
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S608-19. PubMed ID: 21989663
[TBL] [Abstract][Full Text] [Related]
12. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
13. Using CD133 positive U251 glioblastoma stem cells to establish nude mice model of transplanted tumor.
Jin F; Gao C; Zhao L; Zhang H; Wang HT; Shao T; Zhang SL; Wei YJ; Jiang XB; Zhou YP; Zhao HY
Brain Res; 2011 Jan; 1368():82-90. PubMed ID: 20971095
[TBL] [Abstract][Full Text] [Related]
14. CD133 is essential for glioblastoma stem cell maintenance.
Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
[TBL] [Abstract][Full Text] [Related]
15. Expression of multidrug resistance genes in normal and cancer stem cells.
Shervington A; Lu C
Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
[TBL] [Abstract][Full Text] [Related]
16. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
[TBL] [Abstract][Full Text] [Related]
17. GFAP-expressing cells in the postnatal subventricular zone display a unique glial phenotype intermediate between radial glia and astrocytes.
Liu X; Bolteus AJ; Balkin DM; Henschel O; Bordey A
Glia; 2006 Oct; 54(5):394-410. PubMed ID: 16886203
[TBL] [Abstract][Full Text] [Related]
18. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
19. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
20. Cellular organization of the central canal ependymal zone, a niche of latent neural stem cells in the adult mammalian spinal cord.
Hamilton LK; Truong MK; Bednarczyk MR; Aumont A; Fernandes KJ
Neuroscience; 2009 Dec; 164(3):1044-56. PubMed ID: 19747531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
